Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax.
- Resource Type
- Article
- Source
- Cell Death & Disease; Oct2022, Vol. 13 Issue 10, p1-13, 13p
- Subject
- Language
- ISSN
- 20414889